| Drug Name: | Aripiprazole (129722-12-9) |
|---|---|
| PubChem ID: | 60795 |
| SMILES: | C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl |
| InchiKey: | CEUORZQYGODEFX-UHFFFAOYSA-N |
| Therapeutic Category: | Antipsychotic Agents, Central Nervous System Agents, Central Nervous System Depressants, Psychotropic Drugs, Tranquilizing Agents |
| Molecular Weight (dalton) | : | 448.394 |
| LogP | : | 4.8593 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 4 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 44.81 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Fluoxetine (54910-89-3) | Extrapyramidal Disorder | Synergistic | Fluoxitine inhibit the metabolism of antipsychotics by the cytochrome P450 isoenzyme CYP2D6,increase the level of Aripiprazole | Practical prescribing with aripiprazole in schizophrenia: consensus recommendations of a UK multidisciplinary panel |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category